Fisher, M D <br/><br/>
Phase II and phase III trials: docetaxel/irinotecan versus docetaxel/cisplatin in advanced non-small-cell lung cancer (WJTOG 9803).  [electronic resource] 

 -  Clinical lung cancer  Feb 2001 
 - 178-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-7304 
<br/><br/><label>Standard No.: </label>10.1016/s1525-7304(11)70717-3  doi